Articaine Plus Dexmedetomidine in Supraclavicular Block

Launched by BENHA UNIVERSITY · May 16, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of combining two medications, articaine and dexmedetomidine, to manage pain after upper limb surgery. Articaine is a local anesthetic that helps numb the area for a shorter time compared to other anesthetics, while dexmedetomidine may help extend the numbness and reduce pain. The aim is to find out if adding dexmedetomidine to articaine can help patients regain movement more quickly while still providing effective pain relief, which is especially important for those who need to start physical therapy soon after their surgery.

To be eligible for this trial, participants must be between 18 and 60 years old and scheduled for upper limb surgery lasting less than 90 minutes. Certain individuals, such as those with allergies to local anesthetics, serious health conditions, or infections at the injection site, would not be able to participate. If you join the trial, you can expect to receive the study medications during your surgery and be monitored for how well they help with pain and recovery. This research is important as it could lead to better pain management strategies for patients undergoing similar procedures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • aged 18-60 years planned for upper limb surgery below the midhumerus with an expected time of less than 90 min usually under tourniquet.
• Exclusion Criteria:
• • allergies to local anesthetic,
• • those with ASA III and IV,
• • patients who refuse to participate,
• • uncooperative patients,
• • patients who have infection at the site of injection,
• • patients who have bleeding disorder, and patients on anticoagulant drugs.